Lumefantrine USP: API of Choice for Pharma Firms
Introduction The quality of an active pharmaceutical ingredient directly affects the safety, consistency, and performance of the finished medicine. In antimalarial formulations, Lumefantrine USP is an important pharmaceutical ingredient used in combination with artemether to treat uncomplicated malaria caused by Plasmodium falciparum , including infections in areas where drug resistance is a concern. For pharmaceutical companies developing or manufacturing antimalarial medicines, selecting the right API supplier involves more than comparing prices. Buyers need to consider pharmacopoeial compliance, impurity control, batch consistency, documentation, and reliable supply. These factors make supplier qualification an essential part of pharmaceutical procurement. Understanding the technical and commercial requirements associated with Lumefantrine API helps pharmaceutical firms make informed sourcing decisions for regulated and emerging markets. What Is Lumefantrine USP? Lumefantrin...